Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Vemurafenib for Thyroid Cancer
Recruiting1 award16 criteria
New York, New York
This trial tests the effects of vemurafenib on thyroid cancer patients. If successful, vemurafenib could become a new treatment for thyroid cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.